Over 10 countries looking to imbibe India's generic pharmacy model: Report
New Delhi: In an effort to provide affordable medicines to the public, more than 10 countries are looking to imbibe India's generic pharmacy model, as per recent reports.
Mauritius became the first nation to unveil the International Janaushadhi Kendra in July, facilitating access to around 250 high-quality medicines sourced from the Pharmaceuticals and Medical Devices Bureau of India (PMBI). These medicines includes cardiovascular, analgesic, ophthalmic, and anti-allergic drugs.
According to IANS, Nepal, Sri Lanka, Bhutan, Ghana, Suriname, Nicaragua, Mozambique, the Solomon Islands, and Taliban-ruled Afghanistan, are already considering opening Jan Aushadhi Kendras.
Meanwhile, countries like Burkina Faso, Fiji Islands, and Saint Kitts and Nevis are in talks with the government to help them replicate the scheme, revealed the report.
Pradhan Mantri Bharatiya Janaushadhi Pariyojana (PMBJP) is a public welfare scheme, launched by the Prime Minister Narendra Modi-led Central government in November 2008, to provide quality medicines at affordable prices to the masses through special centres named Jan Aushadhi Kendras.
In 2014, there were only 80 Jan Aushadhi Kendras. Till September 2024, a total of 13,822 Jan Aushadhi Kendras have been established across the country, as per official data.
In September, these Kendras also achieved record sales of Rs 200 crore -- the highest monthly sales in the history of the PMBJP.
In the last 10 years, the sale of medicines worth Rs. 6100 crores has been done through Kendras, helping people save an estimated Rs. 30,000 crore.
The price of medicines, surgical devices and nutraceutical products are cheaper at least by 50 per cent at the Jan Aushadhi Kendras, and in some cases, by 80 to 90 per cent of the market price of branded medicines.
The Union government has set a target of opening 25,000 Jan Aushadhi Kendras across the country by March 2026.
Read also: Record sales of Rs 200 crore achieved by Jan Aushadhi Kendras in September
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.